X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
care and treatment (2) 2
hematology (2) 2
index medicus (2) 2
multicenter (2) 2
oncology (2) 2
transplantation (2) 2
abridged index medicus (1) 1
aged (1) 1
allogeneic (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
bacterial (1) 1
bone marrow (1) 1
bortezomib (1) 1
bortezomib - administration & dosage (1) 1
bortezomib - therapeutic use (1) 1
clinical trial (1) 1
clinical-trials (1) 1
complications and side effects (1) 1
consensus development project (1) 1
corticosteroids (1) 1
criteria (1) 1
cytomegalovirus infections (1) 1
death (1) 1
diagnosis (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
everolimus (1) 1
experience (1) 1
female (1) 1
gvhd (1) 1
hematopoietic stem cells (1) 1
humans (1) 1
immunology (1) 1
incidence (1) 1
infection (1) 1
lymphoma, non-hodgkin - drug therapy (1) 1
lymphoma, non-hodgkin - mortality (1) 1
male (1) 1
malignancies (1) 1
multiple-myeloma (1) 1
non-hodgkin lymphoma (1) 1
non-hodgkin's lymphomas (1) 1
non‐hodgkin lymphoma (1) 1
phase 2 (1) 1
proteasome inhibitor bortezomib (1) 1
ruxolitinib (1) 1
single-agent temsirolimus (1) 1
sirolimus - administration & dosage (1) 1
sirolimus - analogs & derivatives (1) 1
sirolimus - therapeutic use (1) 1
steroid-refractory (1) 1
temsirolimus (1) 1
therapy (1) 1
transplant (1) 1
trial (1) 1
wisconsin (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 5192 - 5192
Abstract Introduction: The outcome of adult patients with relapsed/refractory ALL remains dismal. In pediatric patients with relapsed/refractory ALL, the... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5843 - 5843
Abstract Introduction: The development of tyrosine kinase inhibitors (TKIs) has markedly improved the prognosis of patients (pts) with chronic myeloid leukemia... 
Journal Article
Leukemia Research, ISSN 0145-2126, 05/2019, Volume 80, pp. 40 - 42
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3440 - 3440
Background: Tyrosine kinase inhibitor (TKI) therapy has led to phenomenal improvement in overall survival for patients with CML. Since TKI therapies were... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 3837 - 3837
Background: Outcomes of patients with AML have remained poor despite the availability of cytotoxic chemotherapy, hypomethylating agents (HMAs) and targeted... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.